Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CRBP........................
$CRBP 60 million cash and new slide deck just out https://t.co/rmXiR8VV8u https://t.co/F5JlC5oVXk pic.twitter.com/WBaeHVfNie
— dough (@semodough) March 16, 2023
CRBP.......................................squeezzzzzzzzzzzzzzzze...........http://shortvolumes.com/?t=crbp
Good pipeline news. Watching. R/S tomorrow 1:30.
CRBP
CRBP........................https://www.tradingview.com/x/af5HLESa/
CRBP.....................................https://stockcharts.com/h-sc/ui?s=CRBP&p=W&b=5&g=0&id=p86431144783
CRBP.................................http://shortvolumes.com/?t=crbp
CRBP................................https://stockcharts.com/h-sc/ui?s=CRBP
A secondary, obviously, yes
Yes of course I did. What's next? LOL
did you miss this today also?
This site used to be very popular, not anymore.
I remember 20 years ago was different, we all moved to other apps and platforms.
Yeah, I have been seeing this lately. Stocks, running, and no one’s on iHub.
This stock is up nearly 70% today and no one is chatting about it here? I guess this shows the popularity of this site.
What’s going on? I like the accumulation off 52 low weekly rsi.
Nice volume too.
Thank you DollarDan.
BioSpace put out this story yesterday. Maybe it is the reason.
https://www.biospace.com/article/beyond-anti-pd-1-pd-li-3-companies-swing-for-the-fences-with-new-targets-/?keywords=corbus
Volume pouring in on NO NEWS!
NOPE---------Just us chickens
oh ya and reindeer
Are there any catalysts here?
will leave this buying to Doctors---they can afford to lose
so far-am 0 for 3
Picked up this am, wow lots of bargains today
This is gona gap up to 7 ez. Im surprised there isnt alot of chatter about this stock in this forum
* * $CRBP Video Chart 02-10-2021 * *
Link to Video - click here to watch the technical chart video
Over reaction to some not so great new.
Rich getting richer, Go $CRBP!
This will be a big squeeze play I loaded up sub 2.00. With yesterdays volume and gaps at 6.00ish and 9.00ish we got lots of room to run INO
Bad test results.
Somebody please can tell me why is this dropped in last year in select ember from 10$?
* * $CRBP Video Chart 02-02-2021 * *
Link to Video - click here to watch the technical chart video
ROCE Insights For Corbus Pharmaceuticals
2/2/21, 10:44 AM
February 2, 2021 10:44 AM ET (BZ Newswire) -- Earnings
During Q3, Corbus Pharmaceuticals (NASDAQ:CRBP) brought in sales totaling $1.23 million. However, earnings decreased 10.92%, resulting in a loss of $33.97 million. Corbus Pharmaceuticals collected $286.35 thousand in revenue during Q2, but reported earnings showed a $38.14 million loss.
Why ROCE Is Significant
Changes in earnings and sales indicate shifts in Corbus Pharmaceuticals's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, Corbus Pharmaceuticals posted an ROCE of -1.16%.
It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.
ROCE is an important metric for the comparison of similar companies. A relatively high ROCE shows Corbus Pharmaceuticals is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and earnings per share growth.
In Corbus Pharmaceuticals's case, the ROCE ratio shows the amount of assets may not be helping the company achieve higher returns. Investors may take this into account before making any long-term financial decisions.
Q3 Earnings Insight
Corbus Pharmaceuticals reported Q3 earnings per share at $-0.43/share, which did not meet analyst predictions of $-0.42/share.
Copyright © 2021 Benzinga (BZ Newswire, http://www.benzinga.com/licensing). Benzinga does not provide investmentadvice. All rights reserved. Write to editorial@benzinga.com with any questions about this content. Subscribe to Benzinga Pro (http://pro.benzinga.com).
The Financials look like shit
trying to make a comeback----typical farm team
don't pay to much attntion to pre-market. It,s easier to manipulate. I like to see they make it pullback and clean the market
It looks horrible right now, what gives? Offering was at $6, the only thing is shorts are piling on.
By the trading, it looks not today lol
Followers
|
74
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1045
|
Created
|
04/16/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |